DCM
TEVA icon

Dynamic Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Dynamic Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$315K Buy
+45,784
New +$351K 2.63% 13
2019
Q2 		– Sell
-23,828
Closed -$374K – 80
2019
Q1 		$374K Buy
23,828
+8,866
+59% +$156K 1.35% 24
2018
Q4 		$231K Sell
14,962
-3,941
-21% -$80.8K 2.9% 17
2018
Q3 		$407K Buy
+18,903
New +$439K 0.55% 48
2018
Q2 		– Sell
-35,209
Closed -$602K – 147
2018
Q1 		$602K Buy
+35,209
New +$687K 1.5% 18
2017
Q4 		– Sell
-239,126
Closed -$4.21M – 315
2017
Q3 		$4.21M Buy
+239,126
New +$5.38M 1.21% 19
2016
Q4 		– Sell
-94,781
Closed -$4.36M – 459
2016
Q3 		$4.36M Buy
94,781
+31,184
+49% +$1.63M 0.56% 37
2016
Q2 		$3.19M Buy
63,597
+48,419
+319% +$2.58M 0.37% 70
2016
Q1 		$812K Buy
15,178
+11,944
+369% +$701K 0.3% 88
2015
Q4 		$212K Sell
3,234
-28,340
-90% -$1.75M 0.1% 319
2015
Q3 		$1.78M Buy
+31,574
New +$2.05M 0.49% 59
2015
Q1 		– Sell
-4,700
Closed -$270K – 354
2014
Q4 		$270K Buy
+4,700
New +$262K 0.14% 197
2014
Q3 		– Sell
-12,700
Closed -$666K – 440
2014
Q2 		$666K Buy
+12,700
New +$649K 0.19% 186
2013
Q4 		– Sell
-10,505
Closed -$397K – 492
2013
Q3 		$397K Buy
+10,505
New +$410K 0.09% 324

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Dynamic Capital Management's TEVA Position: Q3 2019 in Review

Dynamic Capital Management opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2019: 45,784 shares worth $315K. The stake represents 2.63% of the portfolio and ranks #13 among its holdings. This is a return to the name: Dynamic Capital Management previously reported a position in TEVA as recently as Q1 2019.

Dynamic Capital Management first reported a position in TEVA in Q3 2013 and has held it in 14 quarters since. The position peaked at $4.36M in Q3 2016. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Dynamic Capital Management held 45,784 shares of Teva Pharmaceuticals worth $315K as of Q3 2019.
  • Teva Pharmaceuticals was a new Dynamic Capital Management position in Q3 2019.
  • Teva Pharmaceuticals made up 2.63% of Dynamic Capital Management's portfolio in Q3 2019, its #13 holding.
  • Dynamic Capital Management first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • Dynamic Capital Management's Teva Pharmaceuticals position peaked at $4.36M in Q3 2016.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Dynamic Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.